Test Price
2,800 AED✅ Home Collection Available
SLC39A13 Gene Spondylocheirodysplasia, Ehlers-Danlos Syndrome‑like Genetic Test in UAE | 2,800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The SLC39A13 genetic test utilises Next‑Generation Sequencing (NGS) to detect pathogenic variants in the SLC39A13 gene, causing Spondylocheirodysplasia and Ehlers‑Danlos syndrome‑like presentations. This analysis provides full coding region coverage and precise genotype information essential for accurate diagnosis and personalised management.
| Feature | ✅ Our Test (SLC39A13 NGS) | Closest Alternative |
|---|---|---|
| Diagnostic Precision | >99.9% analytical sensitivity, 100% coding coverage | ~90% coverage, limited sensitivity (Sanger or targeted panel) |
| Methodology | Next‑Generation Sequencing (NGS) | Sanger sequencing / targeted genotyping |
| Turnaround Time | 3 – 4 Weeks | 6 – 8 Weeks |
Physician Insight & Safety Protocols
“I reassure every patient that understanding your genetic blueprint is a proactive step toward personalised health. A positive test result is not a verdict, but a tool that—when correlated with clinical findings and family history—empowers you to make informed decisions. Always discuss your results with a qualified genetic counsellor or your specialist.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠️ Medication Safety Notice
Do not discontinue prescribed medication without consulting your doctor. Genetic test results must be interpreted within your complete clinical context.
🚨 Safety Exclusion & Emergency Red Flags
- Exclusion Criteria: Patients with severe haemophilia or active bleeding disorders who cannot provide a sample via FTA card; test not intended for emergency diagnosis.
- Red Flags – Seek Immediate Emergency Care: Sudden severe joint dislocations, acute chest/abdominal pain, unexplained bruising or signs of arterial rupture.
Patient FAQ & Clinical Guidance
1. What does the SLC39A13 gene test detect and why is it important?
Answer: This NGS test identifies pathogenic variants in SLC39A13 causing Spondylocheirodysplasia and Ehlers‑Danlos syndrome‑like features to guide clinical management. It clarifies the molecular diagnosis, helps predict disease progression, and informs family planning decisions.
2. How is the test performed and what is the turnaround time?
Answer: A blood sample is collected via our VIP Mobile Phlebotomy service using an EDTA tube or FTA card, with temperature‑controlled cold‑chain transport. Results are ready within 3–4 weeks. No hospital admission is required.
3. Is the test covered by insurance in the UAE?
Answer: Direct insurance billing is available; simply send your Emirates ID and policy details to +971 54 548 8731 for instant verification. Many UAE insurers reimburse NGS‑based genetic testing when medically indicated and accompanied by a specialist referral.
UAE Regulatory & Data Privacy Adherence
- Data Protection: Fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health Information Security: Adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical Liability: Medical practice governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Quality Assurance: ISO 9001:2015 Certified (INT/EGQ/2509DA/3139).
- DHA License: Facility License Number 1143, Dubai Healthcare City.
Clinical & Logistical Metadata
| Test Name | SLC39A13 Gene Spondylocheirodysplasia, Ehlers-Danlos Syndrome‑like Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA Tube or FTA Card) |
| Methodology Used | Next‑Generation Sequencing (NGS) |
| ICD-10-CM Code | Q79.6 |
| LOINC Code | 81247-9 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians